NPHC -The Company was recently featured in NBC news. www.tinyurl.com/nyloxinNBC
NPHC is OTCBQ
Received orphan drug status in 2015 which lasts for 7yrs
And this came out a few months ago:
NPHC Alert- Research Report out. . is an emerging biotechnology company with both a traditional drug line path, which will require further development, clinical trials, and FDA approvals, and an over-the-counter pain reliever, which is clinically proven to treat moderate to severe pain and chronic pain.http://globalsmallcaps.com/2017/02/14/nutra-pharma-corp/